First Trial of Humanized Anti-CD74 Monoclonal Antibody (MAb), Milatuzumab, in Multiple Myeloma.

被引：0
|
作者：
Kaufman, Jonathan [1 ]
Niesvizky, Ruben [2 ]
Stadtmauer, Edward A. [3 ]
Chanan-Khan, Asher [4 ]
Siegel, David [5 ]
Home, Heather [6 ]
Teoh, Nick [6 ]
Leoni, Matthew J. [6 ]
Wegener, William A. [6 ]
Goldenberg, David M. [6 ]
机构：
[1] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA
[2] New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA
[3] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[4] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[5] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[6] Immunomedics Inc, Morris Plains, NJ USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1266 / 1267
页数：2
相关论文
共 50 条
  • [21] The association of anti-CD74 antibody with spondyloarthropathies
    Colak, Seda
    Turgay, Tahsin Murat
    Kucuksahin, Orhan
    Duman, Mustafa Turker
    Cetinkaya, Hulya
    Toruner, Murat
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2021, 8 (04) : 207 - 210
  • [22] Results of A Phase 1 Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
    Christian, Beth
    Alinari, Lapo
    Jones, Jeffrey A.
    Benson, Don M., Jr.
    Flynn, Joseph M.
    Porcu, Pierluigi
    Lustberg, Mark E.
    Phelps, Mitchell
    Poi, Ming
    Chung, Diana
    Quinion, Carl
    Byrd, John C.
    Wegener, William
    Goldenberg, David M.
    Baiocchi, Robert A.
    Blum, Kristie A.
    BLOOD, 2011, 118 (21) : 1584 - 1584
  • [23] A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach
    Haran, Michal
    Mirkin, Vita
    Braester, Andrei
    Harpaz, Nurith
    Shevetz, Olga
    Shtreiter, Marina
    Greenberg, Shulamit
    Mordich, Orly
    Amram, Orna
    Binsky-Ehrenreich, Inbal
    Marom, Ayelet
    Shachar, Idit
    Herishanu, Yair
    Ruchlemer, Rosa
    Berrebi, Alain
    Valinsky, Liora
    Shtalrid, Mordechai
    Shvidel, Lev
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (01) : 125 - 128
  • [24] Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas
    Martin, Peter
    Furman, Richard R.
    Rutherford, Sarah
    Ruan, Jia
    Ely, Scott
    Greenberg, June
    Coleman, Morton
    Goldsmith, Stanley J.
    Leonard, John P.
    LEUKEMIA & LYMPHOMA, 2015, 56 (11) : 3065 - 3070
  • [25] Preclinical evaluation of a humanized anti-CD74 monoclonal antibody hLL1, for treatment of B-cell malignancies.
    Stein, R
    Burton, JD
    Cardillo, TM
    Qu, ZX
    Ely, SA
    Reddy, P
    Chen, S
    Rosario, A
    Horak, ID
    Hansen, HJ
    Goldenberg, DM
    BLOOD, 2003, 102 (11) : 181A - 181A
  • [26] Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys
    Sapra, P
    Stein, R
    Pickett, J
    Qu, ZX
    Govindan, SV
    Cardillo, TM
    Hansen, HJ
    Horak, ID
    Griffiths, GL
    Goldenberg, DM
    CLINICAL CANCER RESEARCH, 2005, 11 (14) : 5257 - 5264
  • [27] A humanized anti-HM1.24 monoclonal antibody to a plasma cell-specific antigen for the treatment of multiple myeloma.
    Koishihara, Y
    Yoshimura, Y
    Kawai, S
    Ozaki, Y
    Ozaki, S
    Kaiho, S
    Kosaka, M
    BLOOD, 1998, 92 (10) : 107A - 107A
  • [28] CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, STRO-001
    Embry, Millicent
    Li, Xiaofan
    Yu, Abigail
    Abrahams, Cristina
    Greenland, Nancy Y.
    Wen, Kwun Wah
    Jones, Chris
    DeAlmeida, Venita
    Krimm, Stellanie
    Krueger, Sarah
    Matheny, Shannon
    Kline, Toni
    Yam, Alice
    Stafford, Ryan
    Wiita, Arun P.
    Hallam, Trevor
    Lupher, Mark
    Molina, Arturo
    BLOOD, 2017, 130
  • [29] Novel anti-CD84 humanized monoclonal antibody enhances anti-tumor immunity in multiple myeloma
    Gunes, Metin
    Lewinsky, Hadas
    Dang, Jessica
    Ma, Ning
    Vaidehi, Nagarajan
    Janakiram, Murali
    Feng, Mingye
    Shachar, Idit
    Rosen, Steven
    Gunes, E. Gulsen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S91 - S91
  • [30] Humanized Anti-CD26 Monoclonal Antibody Has Anti-Myeloma Efficacy for the Treatment of High-Risk Multiple Myeloma
    Nishida, Hiroko
    Hayashi, Mutsumi
    Morimoto, Chikao
    Sakamoto, Michiie
    Yamada, Taketo
    BLOOD, 2017, 130
12345